6,7-Dimethoxycoumarin Influences the Erythroid Differentiation of Human Chronic Myelogenous Leukemia K562 Cells through Regulating FOXO3/p27 Signal Pathway. Here, FOXO3 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.